X
Celgene scores at ASH18 with double luspatercept data
https://pharmaphorum.com/news/celgene-scores-at-ash18-with-double-luspatercept-data/
ASH
As rituximab biosimilars close in, Roche showcases Gazyva superiority
Roche faces competition against its blockbuster haematology drug
Spark reassures on safety of haemophilia gene therapy
Study of nine patients produce encouraging results
